Their experiments in pre-clinical models proved to be successful, confirming lower
tumour development with the regulation of the proteins that affect production of VLDL (precursors of LDL) and uptake of LDL by receptors from the liver.
Not exact matches
The Lund University research team has looked at how cancer cells communicate
with surrounding cells and how this encourages the
development of malignant
tumours.
«
With this breakthrough it is possible to generate cell models with the same alterations as observed in tumour cells from patients, which will allow us to study their role in tumour development,» says CNIO researcher Sandra Rodríguez - Pera
With this breakthrough it is possible to generate cell models
with the same alterations as observed in tumour cells from patients, which will allow us to study their role in tumour development,» says CNIO researcher Sandra Rodríguez - Pera
with the same alterations as observed in
tumour cells from patients, which will allow us to study their role in
tumour development,» says CNIO researcher Sandra Rodríguez - Perales.
Peng Loh of the National Institute of Child Health and Human
Development in Bethesda, Maryland, and colleagues studied
tumours from 99 people
with liver cancer.
The largest - ever study to sequence the whole genomes of breast cancers has uncovered five new genes associated
with the disease and 13 new mutational signatures that influence
tumour development.
Professor Geoff Pilkington, study co-author and Head of the Brain
Tumour Research Centre, said: «Although this work is still at an early stage, we have demonstrated key elements that are associated with tumour cell binding to blood vessels and this may provide a target for future drug development to prevent the development of secondary tumours in the
Tumour Research Centre, said: «Although this work is still at an early stage, we have demonstrated key elements that are associated
with tumour cell binding to blood vessels and this may provide a target for future drug development to prevent the development of secondary tumours in the
tumour cell binding to blood vessels and this may provide a target for future drug
development to prevent the
development of secondary
tumours in the brain.
The discovery could help
with future
development of novel treatments to prevent metastasis and secondary
tumours.
It could also lead to the
development of new breast cancer drugs to target
tumours with a specific genetic make - up.
Noor talked to us about moving to the UK, developing her research on brain
tumours, and building her research group
with a CRUK Career
Development Fellowship.
Mutations in p53, BRCA1 and chromosome instability are frequently associated
with ovarian
tumour development, but little is know about the cytoskeleton organisation in this type of
tumours.
However, when crossed
with PyMT - Tg mice or MMTV / Neu (mouse mammary
tumour virus promoter - Neu)- Tg mice, the
development and progression of breast cancer were markedly decreased on Slc6a14 − / − background.
In contrast, no Slc6a14 − / − female
with PyMT transgene developed
tumours at 3 months of age; however, at 4 months of age, small
tumour nodules became detectable (Figure 2B), indicating a marked delay in mammary
tumour development in PyMT - Tg mice as a consequence of Slc6a14 deletion.